Keywords: teva, buy, usa-based, cogenesys, millin, deal, bolster
Teva to buy USA-based CoGenesys, in $400 millin deal to bolster biotech
Article | 28 January 2008
Israel's Teva Pharmaceutical Industries says it has entered into a definitive agreement to acquire the privately-held US biopharmaceutical group CoGenesys. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
